Home Vivoryon Therapeutics

Vivoryon Therapeutics

In operation
Post-IPO Round
Developer of Innovative Therapies for Alzheimer's Disease and Cancer

Basic Information

Vivoryon Therapeutics is a Germany-based biopharmaceutical company engaged in research and development, preclinical, and clinical trial activities. The company focuses on developing therapeutic products for the treatment of Alzheimer's disease and cancer. Its pipeline products include PQ912, PQ1565, and the PQ series.
Vivoryon Therapeutics AG
Saxony-Anhalt,Germany
more than 500 people
January 01, 1997
info@vivoryon.com